- Home
- RDWR vs GHRS Comparison
RDWR vs GHRS Comparison
Compare RDWR & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDWR
- GHRS
- Stock Information
- Founded
- RDWR 1996
- GHRS 2018
- Country
- RDWR Israel
- GHRS Ireland
- Employees
- RDWR N/A
- GHRS N/A
- Industry
- RDWR EDP Services
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- RDWR Technology
- GHRS Health Care
- Exchange
- RDWR Nasdaq
- GHRS Nasdaq
- Market Cap
- RDWR 889.9M
- GHRS 868.7M
- IPO Year
- RDWR 1999
- GHRS 2021
- Fundamental
- Price
- RDWR $22.18
- GHRS $10.40
- Analyst Decision
- RDWR Hold
- GHRS Strong Buy
- Analyst Count
- RDWR 4
- GHRS 7
- Target Price
- RDWR $27.00
- GHRS $30.86
- AVG Volume (30 Days)
- RDWR 131.8K
- GHRS 212.1K
- Earning Date
- RDWR 05-07-2025
- GHRS 05-02-2025
- Dividend Yield
- RDWR N/A
- GHRS N/A
- EPS Growth
- RDWR N/A
- GHRS N/A
- EPS
- RDWR 0.14
- GHRS N/A
- Revenue
- RDWR $274,880,000.00
- GHRS N/A
- Revenue This Year
- RDWR $9.54
- GHRS N/A
- Revenue Next Year
- RDWR $7.54
- GHRS N/A
- P/E Ratio
- RDWR $154.93
- GHRS N/A
- Revenue Growth
- RDWR 5.20
- GHRS N/A
- 52 Week Low
- RDWR $16.12
- GHRS $6.00
- 52 Week High
- RDWR $25.00
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- RDWR 48.72
- GHRS 41.32
- Support Level
- RDWR $21.46
- GHRS $10.20
- Resistance Level
- RDWR $23.37
- GHRS $13.21
- Average True Range (ATR)
- RDWR 0.58
- GHRS 0.85
- MACD
- RDWR -0.03
- GHRS -0.12
- Stochastic Oscillator
- RDWR 50.62
- GHRS 11.37
About RDWR Radware Ltd.
Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. The company generates maximum revenue from the United States.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.